Examination of Bcl-2, Bcl-X and bax protein expression in psoriasis
✍ Scribed by Mukadder Koçak; Önder Bozdoǧan; Emel Erkek; Pínar Atasoy; Ahu Birol
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 185 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0011-9059
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background Psoriasis is an inflammatory skin disease characterized by epidermal hyperplasia and greatly accelerated epidermal turnover. The blockage of normal apoptotic process in the epidermis is one of the factors implicated in the pathogenesis of psoriasis.
Objective The purpose of the present study was to elucidate whether bcl‐family proteins are significantly involved in the hypothetical antiapoptotic cascade in lesional psoriatic epidermis.
Methods Twenty‐six lesional biopsy samples of 26 patients with psoriasis and five control specimens from normal skin were studied by immunohistochemical method for the differential expression of pro‐apoptotic bax and antiapoptotic bcl‐2 and bcl‐x proteins.
Results Compared with the normal epidermis, bcl‐2 expression was significantly reduced, whereas bax and bcl‐x were significantly overexpressed in the psoriatic epidermis. The localization of bcl‐2/bax/bcl‐x proteins in the psoriatic epidermis did not show a significant deviation from that in the normal epidermis.
Conclusion These findings indicate a discordant expression of bcl‐2 and bax/bcl‐x in psoriatic epidermis. Increased bcl‐x expression might contribute to the antiapoptotic response in psoriatic keratinocytes. The presence of strong bax expression with a concomitant decrease in bcl‐2 expression suggests either a functional defect in bax protein or an inherent/acquired resistance to bax‐mediated apoptosis in psoriatic keratinocytes.
📜 SIMILAR VOLUMES
Using western blotting and immunochemical analysis, we investigated alterations in the expression of the apoptosis-related proteins bcl-2, bax, and bcl-X in colonic adenocarcinomas induced by subcutaneous injection of azoxymethane (AOM) (15 mg/kg body weight weekly for 2 wk) into male Sprague-Dawley
## Background: Darier's disease (dd) is a rare autosomal dominant disorder of keratinization caused by a mutation of the atp2a2 gene. there is little information on the behaviour of bcl-2, bax and bcl-x in dd. ## Objectives: To investigate the dynamic control and the behaviour of bax, bcl-2 and b
Bcl-2 is a proto-oncogene which is involved in prolonging cell survival by inhibiting programmed cell death. Bax and bcl-x are members of the bcl-2 family; when overexpressed, they can counteract the ability of bcl-2 to inhibit apoptosis. This suggests a model in which the ratios of bcl-2 to bax and